Yin Yang 1-mediated epigenetic silencing of tumour-suppressive microRNAs activates nuclear factor-κB in hepatocellular carcinoma

Journal of Pathology

Volumn 238, Issue 5, 2016, Pages 651-664

  Tsang, Daisy P F ^a   Wu, William K K ^a   Kang, Wei ^a   Lee, Ying Ying ^a   Wu, Feng ^a   Yu, Zhuo ^a   Xiong, Lei ^a   Chan, Anthony W ^a   Tong, Joanna H ^a   Yang, Weiqin ^a   Li, May S M ^a   Lau, Suki S ^a   Li, Xiangchun ^a   Lee, Sau Dan ^a   Yang, Yihua ^a   Lai, Paul B S ^a   Yu, Dae Yeul ^b   Xu, Gang ^a   Lo, Kwok Wai ^a   Chan, Matthew T V ^a   Wang, Huating ^a   Lee, Tin L ^a   Yu, Jun ^a   Wong, Nathalie ^a   Yip, Kevin Y ^a   To, Ka Fai ^a   Cheng, Alfred S L ^a   more..

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

Author keywords

ChIP seq; DNA methylation; EZH2; histone modification; liver cancer

Indexed keywords

DECITABINE; HEPATITIS B VIRUS X PROTEIN; HISTONE H3; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LYSINE; MICRORNA; MICRORNA 9; RNA ISOFORM; TRANSCRIPTION FACTOR EZH2; TRANSCRIPTION FACTOR YY1; EZH2 PROTEIN, HUMAN; HISTONE; POLYCOMB REPRESSIVE COMPLEX 2; TRANSACTIVATOR PROTEIN; YY1 PROTEIN, HUMAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BINDING SITE; CANCER INHIBITION; CANCER SURGERY; CANCER SURVIVAL; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DNA METHYLATION; EPIGENETICS; GENE OVEREXPRESSION; GENE SILENCING; HEPATITIS B VIRUS; HIGH THROUGHPUT SEQUENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; LIVER RESECTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; UPREGULATION; ANIMAL; CELL PROLIFERATION; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GENETICS; LIVER TUMOR; METABOLISM; METHYLATION; NUDE MOUSE; PATHOLOGY; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TIME FACTOR; TRANSGENIC MOUSE; TUMOR CELL LINE; TUMOR VOLUME; VIROLOGY;

ANIMALS; APOPTOSIS; BINDING SITES; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CELL PROLIFERATION; DNA METHYLATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; HISTONES; HUMANS; LIVER NEOPLASMS; LYSINE; METHYLATION; MICE, NUDE; MICE, TRANSGENIC; MICRORNAS; NF-KAPPA B; POLYCOMB REPRESSIVE COMPLEX 2; PROMOTER REGIONS, GENETIC; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TIME FACTORS; TRANS-ACTIVATORS; TRANSFECTION; TUMOR BURDEN; UP-REGULATION; YY1 TRANSCRIPTION FACTOR;

EID: 84961774348     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.4688     Document Type: Article

References (48)

1. Sandoval J, Esteller M,. Cancer epigenomics: beyond genomics. Curr Opin Genet Dev 2012; 22: 50-55.
2. Kondo Y, Shen L, Cheng AS, et al., Gene silencing in cancer by histone H3 lysine 27 trimethylation independent of promoter DNA methylation. Nature Genet 2008; 40: 741-750.
3. Cheng AS, Lau SS, Chen Y, et al., EZH2-mediated concordant repression of Wnt antagonists promotes beta-catenin-dependent hepatocarcinogenesis. Cancer Res 2011; 71: 4028-4039.
4. Feng H, Yu Z, Tian Y, et al., A CCRK-EZH2 epigenetic circuitry drives hepatocarcinogenesis and associates with tumor recurrence and poor survival of patients. J Hepatol 2015; 62: 1100-1111.
5. Schwartz YB, Pirrotta V,. A new world of Polycombs: unexpected partnerships and emerging functions. Nature Rev Genet 2013; 14: 853-864.
6. Yu Z, Cheng AS,. Epigenetic deregulation of microRNAs: new opportunities to target oncogenic signaling pathways in hepatocellular carcinoma. Curr Pharm Des 2013; 19: 1192-1200.
7. Law PT, Wong N,. Emerging roles of microRNA in the intracellular signaling networks of hepatocellular carcinoma. J Gastroenterol Hepatol 2011; 26: 437-449.
8. Anwar SL, Albat C, Krech T, et al., Concordant hypermethylation of intergenic microRNA genes in human hepatocellular carcinoma as new diagnostic and prognostic marker. Int J Cancer 2013; 133: 660-670.
9. Furuta M, Kozaki KI, Tanaka S, et al., miR-124 and miR-203 are epigenetically silenced tumor-suppressive microRNAs in hepatocellular carcinoma. Carcinogenesis 2010; 31: 766-776.
10. Lu CY, Lin KY, Tien MT, et al., Frequent DNA methylation of miR-129-2 and its potential clinical implication in hepatocellular carcinoma. Genes Chromosomes Cancer 2013; 52: 636-643.
11. Au SL, Wong CC, Lee JM, et al., Enhancer of zeste homolog 2 epigenetically silences multiple tumor suppressor microRNAs to promote liver cancer metastasis. Hepatology 2012; 56: 622-631.
12. Yu Z, Gao YQ, Feng H, et al., Cell cycle-related kinase mediates viral-host signalling to promote hepatitis B virus-associated hepatocarcinogenesis. Gut 2014; 63: 1793-1804.
13. Chng KR, Chang CW, Tan SK, et al., A transcriptional repressor co-regulatory network governing androgen response in prostate cancers. EMBO J 2012; 31: 2810-2823.
14. Kim E, Kim M, Woo DH, et al., Phosphorylation of EZH2 activates STAT3 signaling via STAT3 methylation and promotes tumorigenicity of glioblastoma stem-like cells. Cancer Cell 2013; 23: 839-852.
15. Caretti G, Di Padova M, Micales B, et al., The Polycomb Ezh2 methyltransferase regulates muscle gene expression and skeletal muscle differentiation. Genes Dev 2004; 18: 2627-2638.
16. Lee TI, Jenner RG, Boyer LA, et al., Control of developmental regulators by Polycomb in human embryonic stem cells. Cell 2006; 125: 301-313.
17. Kalinowski FC, Brown RA, Ganda C, et al., microRNA-7: a tumor suppressor miRNA with therapeutic potential. Int J Biochem Cell Biol 2014; 54: 312-317.
18. Tsai KW, Liao YL, Wu CW, et al., Aberrant hypermethylation of miR-9 genes in gastric cancer. Epigenetics 2011; 6: 1189-1197.
19. Li Z, Lei H, Luo M, et al., DNA methylation downregulated mir-10b acts as a tumor suppressor in gastric cancer. Gastric Cancer 2015; 18: 43-54.
20. Yang G, Zhang R, Chen X, et al., MiR-106a inhibits glioma cell growth by targeting E2F1 independent of p53 status. J Mol Med (Berl) 2011; 89: 1037-1050.
21. Chiyomaru T, Enokida H, Tatarano S, et al., miR-145 and miR-133a function as tumour suppressors and directly regulate FSCN1 expression in bladder cancer. Br J Cancer 2010; 102: 883-891.
22. Liu Z, Zhang G, Li J, et al., The tumor-suppressive microRNA-135b targets c-myc in osteoscarcoma. PLoS One 2014; 9: e102621.
23. Niu G, Li B, Sun L, et al., MicroRNA-153 inhibits osteosarcoma cells proliferation and invasion by targeting TGF-β2. PLoS One 2015; 10: e0119225.
24. Li Y, Zhang M, Chen H, et al., Ratio of miR-196 s to HOXC8 messenger RNA correlates with breast cancer cell migration and metastasis. Cancer Res 2010; 70: 7894-7904.
25. Song L, Huang Q, Chen K, et al., miR-218 inhibits the invasive ability of glioma cells by direct downregulation of IKK-beta. Biochem Biophys Res Commun 2010; 402: 135-140.
26. Schlesinger Y, Straussman R, Keshet I, et al., Polycomb-mediated methylation on Lys27 of histone H3 pre-marks genes for de novo methylation in cancer. Nature Genet 2007; 39: 232-236.
27. Vergoulis T, Vlachos IS, Alexiou P, et al., TarBase 6.0: capturing the exponential growth of miRNA targets with experimental support. Nucleic Acids Res 2012; 40: D222-D229.
28. Ning BF, Ding J, Liu J, et al., Hepatocyte nuclear factor 4α-nuclear factor-κB feedback circuit modulates liver cancer progression. Hepatology 2014; 60: 1607-1619.
29. Bazzoni F, Rossato M, Fabbri M, et al., Induction and regulatory function of miR-9 in human monocytes and neutrophils exposed to proinflammatory signals. Proc Natl Acad Sci U S A 2009; 106: 5282-5287.
30. Yang G, Han D, Chen X, et al., MiR-196a exerts its oncogenic effect in glioblastoma multiforme by inhibition of IκBα both in vitro and in vivo. Neuro Oncol 2014; 16: 652-661.
31. Wang L, Zhang X, Jia LT, et al., c-Myc-mediated epigenetic silencing of microRNA-101 contributes to dysregulation of multiple pathways in hepatocellular carcinoma. Hepatology 2014; 59: 1850-1863.
32. Yang F, Zhang L, Huo XS, et al., Long noncoding RNA high expression in hepatocellular carcinoma facilitates tumor growth through enhancer of zeste homolog 2 in humans. Hepatology 2011; 54: 1679-1689.
33. Pan X, Papasani M, Hao Y, et al., YY1 controls Igκ repertoire and B-cell development, and localizes with condensin on the Igκ locus. EMBO J 2013; 32: 1168-1182.
34. Basu A, Wilkinson FH, Colavita K, et al., YY1 DNA binding and interaction with YAF2 is essential for Polycomb recruitment. Nucleic Acids Res 2014; 42: 2208-2223.
35. Shi J, Hao A, Zhang Q, et al., The role of YY1 in oncogenesis and its potential as a drug target in cancer therapies. Curr Cancer Drug Targets 2015; 15: 145-157.
36. Zhang L, Cai X, Chen K, et al., Hepatitis B virus protein up-regulated HLJ1 expression via the transcription factor YY1 in human hepatocarcinoma cells. Virus Res 2011; 157: 76-81.
37. Zhang S, Jiang T, Feng L, et al., Yin Yang-1 suppresses differentiation of hepatocellular carcinoma cells through the downregulation of CCAAT/enhancer-binding protein alpha. J Mol Med (Berl) 2012; 90: 1069-1077.
38. Jeon Y, Lee JT,. YY1 tethers Xist RNA to the inactive X nucleation center. Cell 2011; 146: 119-133.
39. Vire E, Brenner C, Deplus R, et al., The Polycomb group protein EZH2 directly controls DNA methylation. Nature 2006; 439: 871-874.
40. Wu H, Coskun V, Tao J, et al., Dnmt3a-dependent nonpromoter DNA methylation facilitates transcription of neurogenic genes. Science 2010; 329: 444-448.
41. Bartke T, Vermeulen M, Xhemalce B, et al., Nucleosome-interacting proteins regulated by DNA and histone methylation. Cell 2010; 143: 470-484.
42. Zhao G, Li Q, Wang A, et al., YY1 regulates melanoma tumorigenesis through a miR-9 ∼ RYBP axis. J Exp Clin Cancer Res 2015; 34: 66.
43. Luedde T, Schwabe RF,. NF-κB in the liver-linking injury, fibrosis and hepatocellular carcinoma. Nature Rev Gastroenterol Hepatol 2011; 8: 108-118.
44. Xu WP, Yi M, Li QQ, et al., Perturbation of microRNA-370/Lin-28 homolog A/nuclear factor kappa B regulatory circuit contributes to the development of hepatocellular carcinoma. Hepatology 2013; 58: 1977-1991.
45. Ding J, Huang S, Wang Y, et al., Genome-wide screening reveals that miR-195 targets the TNF-α/NF-κB pathway by down-regulating IκB kinase α and TAB3 in hepatocellular carcinoma. Hepatology 2013; 58: 654-666.
46. Wang H, Garzon R, Sun H, et al., NF-kappaB-YY1-miR-29 regulatory circuitry in skeletal myogenesis and rhabdomyosarcoma. Cancer Cell 2008; 14: 369-381.
47. Pan X, Jones M, Jiang J, et al., Increased expression of PcG protein YY1 negatively regulates B cell development while allowing accumulation of myeloid cells and LT-HSC cells. PLoS One 2012; 7: e30656.
48. Bonavida B., RKIP-mediated chemo-immunosensitization of resistant cancer cells via disruption of the NF-κB/Snail/YY1/RKIP resistance-driver loop. Crit Rev Oncog 2014; 19: 431-445.